Millennium Management
RCUS icon

Millennium Management’s Arcus Biosciences RCUS Stock Holding History

Millennium Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,800
Closed -$844K – 6770
2022
Q4 		$844K Buy
+40,800
New +$1.12M ﹤0.01% 4329
2022
Q3 		– Sell
-102,300
Closed -$2.59M – 7416
2022
Q2 		$2.59M Sell
102,300
-39,600
-28% -$970K ﹤0.01% 3437
2022
Q1 		$4.48M Buy
+141,900
New +$4.75M ﹤0.01% 3058
2021
Q2 		– Sell
-10,000
Closed -$281K – 7004
2021
Q1 		$281K Hold
10,000
– – ﹤0.01% 5259
2020
Q4 		$260K Buy
+10,000
New +$242K ﹤0.01% 4649

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Millennium Management's RCUS Position: Q1 2026 in Review

Millennium Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 168,876 shares — an estimated $4.02M sold.

Millennium Management first reported a position in RCUS in Q1 2018 and held it in 28 quarters. The position peaked at $13.8M in Q4 2024. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Millennium Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 168,876 Arcus Biosciences shares in Q1 2026, an estimated $4.02M.
  • Millennium Management first reported a position in Arcus Biosciences in Q1 2018 and held it in 28 quarters.
  • Millennium Management's Arcus Biosciences position peaked at $13.8M in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.